Skip to main content
. 2020 Apr 16;51(11):1188–1197. doi: 10.1111/apt.15710

FIGURE 4.

FIGURE 4

The ability of GMLVQ and GMLVQ* to identify advanced NAFLD fibrosis (F3‐4) (A) and cirrhosis (F4) (B) can be refined to a panel of approximately 10 specific steroid metabolites (GMLVQ‐10*) without significant reduction in diagnostic performance. GMLVQ, Generalised Matrix Learning Vector Quantisation; NAFLD, non‐alcoholic fatty liver disease